Envoy Medical, Inc. - Class A Common Stock (COCH)
Healthcare › Orthopedic, Prosthetic & Surgical Appliances & Supplies
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- P/B of 5.69 — trading above book value
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -211.8%
- Revenue growing at 7% annually
Envoy Medical, Inc. - Class A Common Stock (COCH) is a Healthcare company operating in Orthopedic, Prosthetic & Surgical Appliances & Supplies, listed on the NASDAQ , with a market capitalisation of $58 million . Key value metrics: P/B ratio 5.69, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 4 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Envoy Medical, Inc. - Class A Common Stock — Fundamental Analysis Summary
On financial health, COCH shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -211.8% (sector average: -20.6%).
StockPik's composite Value Score for COCH is 15/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
COCH reports a thin gross margin of -376.1% (sector average: 39.4%) and a negative operating margin of -10,655.6%.
COCH shows revenue growing at 7% year-over-year, with earnings declining at 14%.